3A77-28: TEST KIT,HUMAN IMMUNODEFICIENCY.
TEST KIT,HUMAN IMMUNODEFICIENCY. Key specifications include usage_design: FOR DETECTION OF HIV TYPE 1 AND/OR TYPE 2, test_capability_quantity: 100, total_primary_container_quantity: 11, part_name_assigned_by_controlling_agency: TEST KIT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND/OR 2 100 TESTS. This part is cataloged in the U.S.
Government catalog under NSN 6550-01-358-0777, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| usage_design | FOR DETECTION OF HIV TYPE 1 AND/OR TYPE 2 |
| test_capability_quantity | 100 |
| total_primary_container_quantity | 11 |
| part_name_assigned_by_controlling_agency | TEST KIT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND/OR 2 100 TESTS |
| NSN | 6550-01-358-0777 |
| TEST CAPABILITY QUANTITY | 100 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | TEST KIT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND/OR 2 100 TESTS |
| USAGE DESIGN | FOR DETECTION OF HIV TYPE 1 AND/OR TYPE 2 |
| COMPONENT BREAKDOWN WITHIN EACH TEST KIT | 1 VIAL ANTGEN COATED BEADS (100 EA); TWO 0.65ML VIAL CONJUGATE CONCENTRATE; TWO 12.35ML VIAL CONJUGATE DILUENT; ONE 3ML VI HIV-1 POSITIVE CONTROL (HUMAN); ONE 6ML VIAL HIV-2 POSITIVE CONTROL (MOUSE MONOCLONAL); ONE 4ML VI NEGATIVE CONTROL (HUMAN); ONE 15ML VIAL SPECIMEN DILUTENT; ONE BOTTLE OPD TABLETS (10 TABLETS); ONE 55ML BOTTLE DILUENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 11 |